FitLife Brands, Inc. (FTLF)
Nasdaq: FTLF · Medicinal Chemicals & Botanical Products · Omaha, NE · filing with the SEC since 2006
Grade5.8
◀ Past 5.3● Present 5.8▶ Future 6.5
Who owns FitLife Brands, Inc.
As filed with the SECHolders of 5% or more
1
Askeladden Capital Management LLC holds 7% of Common Stock, as its SCHEDULE 13G/A filed Aug 7, 2026 says.
Directors and officers
6
report now, of 13 people on the record since 2010. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Askeladden Capital Management LLC
SCHEDULE 13G/A · filed Aug 7, 2026 · Common Stock · 5.4% in Feb 14, 2025
What FTLF reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Irwin Naturals
A company bought · acquisition, asset acquisition · Jul 2025 · owns, named in the 10-K filed Mar 31, 2026
6 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 31, 2026.
Insider tradesForm 4
0sales
4purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 13 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Pappas Shannon K. | director | 0 | $0 | 0 | 1 | $0 |
| Yakatan Seth | director | 0 | $0 | 0 | 1 | $0 |
| Dawson Grant Robert | director | 0 | $0 | 0 | 1 | $0 |
| Lingenbrink Matthew | director | 0 | $0 | 0 | 1 | $0 |